Ivan Vogelius

Publications

• Dose–Effect Relationships in Modern Radiation Oncology Mathematical Models, Clinical Outcome, Statistical Inference
• Proton vs photon radiation therapy for glioblastoma: Maximizing information from trial
• Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study
• A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients
• An extended hypofractionated palliative radiotherapy regimen for head and neck carcinomas
• Dose Response and Fractionation Sensitivity of Prostate Cancer After External Beam Radiation Therapy: A Meta-analysis of Randomized Trials
• Comparison of EORTC QLQ-C30 and PRO-CTCAE™ Questionnaires on Six Symptom Items
• Individualized estimates of overall survival in radiation therapy plan optimization — A concept study
• A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non–Small Cell Lung Cancer
• A failure-type specific risk prediction tool for selection of head-and-neck cancer patients for experimental treatments
• Retrospective estimation of heart and lung doses in pediatric patients treated with spinal irradiation
• Accumulated dose implications from systematic dose-rate transients in gated treatments with Viewray MRIdian accelerators
• Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma
• The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis
• Harnessing data science to advance radiation oncology
• Dose-accumulation analysis of target and organs at risk with clinical outcome after re-irradiation of diffuse midline glioma
• Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy
• A systematic review on clinical adaptive radiotherapy for head and neck cancer
• Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung Tumors
• Comparing the patients’ subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires
• On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer
• Dual-energy material decomposition for cone-beam computed tomography in image-guided radiotherapy
• An investigative expansion of a competing risk model for first failure site in locally advanced non-small cell lung cancer
• Systematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trial
• ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
• Deep learning for identification of critical regions associated with toxicities after liver stereotactic body radiation therapy.
• Multiple Testing, Cut-Point Optimization, and Signs of Publication Bias in Prognostic FDG-PET Imaging Studies of Head and Neck and Lung Cancer: A Review and Meta-Analysis.
• In Reply to Berk and Alfonso.
• Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold.
• Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database.
• Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer.
• Feasibility of Multiparametric Positron Emission Tomography/Magnetic Resonance Imaging as a One-Stop Shop for Radiation Therapy Planning for Patients with Head and Neck Cancer.
• Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
• Does multiparametric imaging with 18F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
• Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations.
• Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studies.
• Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer.
• Radiation dose-painting with protons vs. photons for head-and-neck cancer.
• Heterogeneity in tumours: Validating the use of radiomic features on 18F-FDG PET/CT scans of lung cancer patients as a prognostic tool.
• High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma.
• FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy.
• Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy.
• Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients.
• Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer.
• Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study
• Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study (Preprint)
• A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma
• Toward PET/MRI as one-stop shop for radiotherapy planning in cervical cancer patients
• Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study
• Novel technologies in radiotherapy in the Nordic countries - report from the NACP2020/21 conference
• Dose-effect relationships in modern radiation oncology
• Failure-probability driven dose painting
• A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis
• Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma
• Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma
• A method to adjust radiation dose-response relationships for clinical risk factors
• Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold
• Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer
• Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma
• Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy
• Prescribing and evaluating target dose in dose-painting treatment plans
• Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer
• Cardiovascular disease after treatment for Hodgkin's lymphoma: An analysis of nine collaborative EORTC-LYSA trials
• Reduced lung dose and improved inspiration level reproducibility in visually guided DIBH compared to audio coached EIG radiotherapy for breast cancer patients
• The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma
• Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: Bad news, good news, or no news?
• Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: Minimizing the life years lost attributable to failure to control the disease and late complication risk
• Hypofractionated radiation therapy for prostate cancer: More food for thought from recent trial
• Interactive decision-support tool for risk-based radiation therapy plan comparison for hodgkin lymphoma
• Dose-response of acute urinary toxicity of long-course preoperative chemoradiotherapy for rectal cancer
• In reply to Arcangeli et al
• Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma
• Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale
• A DICOM based radiotherapy plan database for research collaboration and reporting
• The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma
• Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis
• Feasibility of multiparametric imaging with PET/MR in head and neck Squamous cell carcinoma
• A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy
• Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma
• Early lesion-specific 18F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer
• Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting
• Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors
• Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy
• Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma
• SU‐E‐T‐167: QA of Dose‐Painting Plans: Risk of Overdosage in the High‐Dose Regions?
• Minimizing late effects for patients with mediastinal Hodgkin lymphoma: Deep inspiration breath-hold, IMRT, or both?
• Doses to carotid arteries after modern radiation therapy for hodgkin lymphoma: Is stroke still a late effect of treatment?
• Modeling freedom from progression for standard-risk medulloblastoma: A mathematical tumor control model with multiple modes of failure
• Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma
• A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer: In regard to Arcangeli C, et al. (Int J Radiat Oncol Biol Phys 2010;78:11-18)
• Reproducibility of 18F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR
• A closer look at RapidArc® radiosurgery plans using very small fields
• Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake
• Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan
• Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma
• Hippocampal sparing radiotherapy for pediatric medulloblastoma: Impact of treatment margins and treatment technique
• Modern Hypofractionation Schedules for Tangential Whole Breast Irradiation Decrease the Fraction Size-corrected Dose to the Heart
• Long-term results of a randomized trial in locally advanced rectal cancer: No benefit from adding a brachytherapy boost
• Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data,Modellierung der Tumorkontrollwahrscheinlichkeit für räumlich inhomogenes Rezidivrisiko basierend auf klinischen Daten
• A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma
• In response to Dr. Williams
• Risk factors for radiation-induced hypothyroidism: A literature-based meta-analysis
• Correlated emission of three α-particles in the β-decay of 12n
• Clarification of the Three-Body Decay of 12C (12.71 MeV)
• Artifacts in conventional computed tomography (CT) and free breathing four-dimensional CT induce uncertainty in gross tumor volume determination
• Rotational cooling of heteronuclear molecular ions with1Σ, 2Σ, 3Σ, and2II electronic ground states
• SU‐FF‐T‐519: Potential for Increased Pneumonitis Risk with IMRT as Compared to 3D‐CRT for Patients Receiving Adjuvant Chemotherapy: A Radiobiological Modeling Study
• Absorption measurements on a new cone beam CT and IMRT compatible tabletop for use in external radiotherapy
• Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques
• Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes
• Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking
• Rotational cooling of molecules using lamps
• Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: A modeling study of dose dumping
• Dynamics of a single Rydberg shell in time dependent external fields
• Radiation Dose-Volume Effects in the Lung
• A New Method for Synthesizing Radiation Dose-Response Data From Multiple Trials Applied to Prostate Cancer
• New information on 12C states from the decays of 12N and 12B
• News on 12C from β-decay studies
• Photo-dissociation of Cold MgH+ ions: Towards rotational temperature measurements and controlled dissociation
• Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma
• Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer
• Rotational cooling of molecular ions through laser-induced coupling to the collective modes of a two-ion Coulomb crystal
• Probabilistic state preparation of a single molecular ion by projection measurement